# KYMERA THERAPEUTICS, INC. (KYMR) FY2026 YTD Q3 P&L / Income Statement

- Company: KYMERA THERAPEUTICS, INC. (KYMR)
- Period: 2026-01-01 to 2026-09-30
- Filing: Q3 FY2026 10-Q, filed 2026-10-29, accession number 0001193125-26-436975
- Page: https://plicit.ai/financials/kymr/fy2026-ytd-q3-income-statement
- Chart image: https://plicit.ai/charts/kymr-fy2026-ytd-q3-income-statement-sankey.png

## Chart details

Income statement for 2026-01-01 through 2026-09-30. Consolidated revenue, costs and expenses.

- **Collaboration Revenue**: 99,365,000 US dollars
- **Total operating expenses**: 406,359,000 US dollars
- **Loss from operations**: negative 306,994,000 US dollars
- **Other income (expense), net (calculated)**: 44,550,000 US dollars
- **Income before income taxes (calculated)**: negative 262,444,000 US dollars
- **Net loss**: negative 262,444,000 US dollars
- **Total operating expenses**: 406,359,000 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
